Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide maintenance therapy in primary CNS lymphoma
ChiCTR2000035401Phase 4Recruiting
- Sponsor
- Huashan Hospital
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lenalidomide in primary central nervous system lymphoma (PCNSL) (2 arms), sponsored by Huashan Hospital. Primary endpoints: Progression-free survival and Relapse rate. Started Aug 2020; status: recruiting.
02
Drugs
lenalidomide
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on ChiCTR2000035401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035401.